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Abstract: Erythrocytes are involved in the transport of oxygen and carbon dioxide in the body. Since pH is the inﬂ  uen-
tial factor in the Bohr-Haldane effect, pHi is actively maintained via secondary active transports Na
+/H
+ exchange and 
HC3
-/Cl
- anion exchanger. Because of the redox properties of the iron, hemoglobin generates reactive oxygen species 
and thus, the human erythrocyte is constantly exposed to oxidative damage. Although the adult erythrocyte lacks protein 
synthesis and cannot restore damaged proteins, it is equipped with high activity of protective enzymes. Redox changes 
in the cell initiate various signalling pathways. Plasma membrane oxido-reductases (PMORs) are transmembrane electron 
transport systems that have been found in the membranes of all cells and have been extensively characterized in the 
human erythrocyte. Erythrocyte PMORs transfer reducing equivalents from intracellular reductants to extracellular 
oxidants, thus their most important role seems to be to enable the cell respond to changes in intra- and extra-cellular 
redox environments.
So far the activity of erythrocyte PMORs in disease states has not been systematically investigated. This review sum-
marizes present knowledge on erythrocyte electron transfer activity in humans (health, type 1 diabetes, diabetic nephropa-
thy, and chronic uremia) and hypothesizes an integrated model of the functional organization of erythrocyte plasma membrane 
where electron pathways work in parallel with transport metabolons to maintain redox homeostasis.
Keywords: Human erythrocyte, Na/H exchanger, Plasma membrane oxidoreductase, Type 1 diabetes, Diabetic nephropathy, 
Uremia
Introduction
The erythrocyte is a highly specialized cell whose main functions are oxygen transport and the media-
tion of carbon dioxide transport (Siems et al. 2000). Glycolysis and the oxidative pentose phosphate 
pathway generate NADH and NADPH to reduce methemoglobin, which is being continuously produced, 
and the antioxidant glutathione, which is present in high concentrations. Most of the nonenzymatic 
antioxidant capacity of whole blood is likewise localized in the erythrocytes. Circulating red cells are 
mobile free radical scavengers and provide antioxidant protection to other tissues and organs. At the 
end of their life span (120 ± 4 days) the human erythrocytes become non-self cells and then are phago-
cytosized (Arese et al. 2005). Band 3 modiﬁ  cations, mostly due to oxidative insults, are presumed to 
lead to band 3 oligomerization, anti-band 3 binding, complement activation, opsonization, and phago-
cytosis. Despite increasing evidence in literature that plasma membrane oxidoreductases may have 
several functions, little data exists about the erythrocyte electron transfer systems in humans. The cell 
serves as a model to discuss the physiological and pathological implications of emerging evidence on 
the functional organization of plasma membranes and to highlight the potential role of transmembrane 
electron transfer as redox biomarker.
Erythrocyte Energy Metabolism
The adult erythrocyte lacks the ability to synthesize proteins and cannot restore damaged proteins, but 
it is equipped with high activity of protective enzymes. Energy is needed to maintain hemoglobin (Hb) 
iron in the divalent form, transmembrane gradients of sodium and potassium, the sulfhydryl groups of 
enzymes and Hb in the reduced form, and the biconcave shape of the cell. The red blood cell (RBC) 
lacks citric acid cycle and extracts energy from glucose essentially by anaerobic glycolysis or Embden-
Meyerhof pathway (Beutler, 1986). Branching of the metabolic ﬂ  ow after the formation of 1,3-
diphosphoglycerate (Luebering-Rapaport pathway) determines both the rate of ADP phosphorylation 322
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and the concentration of 2,3-diphosphoglycerate 
whose levels are particularly sensitive to pH. The 
hexose monophosphate shunt reduces NADP
+ 
to NADPH, i.e. the substrate for glutathione 
reductase to generate glutathione (GSH). Under 
normal steady-state conditions, 92% of glucose is 
metabolized by glycolysis and 8% through the 
hexose monophosphate shunt. Under oxidant con-
ditions up to 90% of glucose can be metabolized 
along the hexose monophosphate shunt. Moreover, 
oxygenation-dependent interactions between Hb, 
cytoplasmic factors and cytoskeletal proteins may 
alter erythrocyte properties and metabolism 
(Barvitenko et al. 2004).
Among a number of hormone and cytokine 
receptors (Minetti and Low, 1997; Di Virgilio et al. 
2001), erythrocytes express purinergic P2 receptors 
and at the same time readily release ATP. Therefore, 
they are an ideal “integrator unit” in the blood 
because they are both sensitive to ATP released by 
other blood cells and are able to modulate the func-
tion of circulating or endothelial cells by secreting 
this nucleotide.
Erythrocyte Membrane Skeleton as 
a Membrane Scaffolding
RBC cytoskeleton maintains the biconcave shape 
of the erythrocyte, its reversible deformability and 
membrane structural integrity (Fig. 1). The spectrin 
oligomeric lattice binds to speciﬁ  c classes of inte-
gral membrane proteins through a number of 
accessory proteins (Bennett and Lambert, 1991; 
Mills and Mandel, 1994). The band 3 anion 
exchanger is the major integral protein. Its 
C-terminal cytoplasmic domain binds carbonic 
anhydrase II (CAII); the N-terminal cytoplasmic 
domain (cdb3) binds glycolytic enzymes, Hb, and 
hemichromes. A second site of attachment of the 
RBC membrane to the cytoskeleton is through 
the glycophorin C complex. The existence of the 
Rh protein complex has been also suggested (Bruce 
et al. 2003; Mohandas and An, 2006).
In cell membranes, local inhomogeneity in the 
lateral distribution of lipids and proteins is thought 
to exist in vivo, in the form of lipid rafts and in 
speciﬁ  c classes of proteins, specialized in signal 
transduction, cell-cell recognition, and vesicular 
trafficking. Lipid rafts are proposed to be 
cholesterol- and sphingolipid-rich domains that 
ﬂ  oat in an environment of more ﬂ  uid regions. 
Caveolae represent a subtype of lipid raft that form 
ﬂ  ask-shaped membrane invaginations containing 
the structural protein caveolin1 (Gaus et al. 2006; 
Ciana et al. 2005).
Sorting of biochemical pathways depends on 
the accumulation of proteins within different 
membrane-bound compartments, which exist as 
dynamic membrane systems rather as isolated 
entities. The membrane skeleton possesses char-
acteristics predicted for a membrane protein-
sorting machine (Gaus et al. 2006; Beck and 
Nelson, 1996). In addition to binding ankyrin, 
protein 4.1, protein 4.2, kinases, hemichromes, 
integral membrane proteins, and glycolytic 
enzymes (GE), the N-terminal cytoplasmic domain 
cdb3 associates preferentially with the deoxygen-
ated state (T state) of Hb. Indeed, human cdb3 
competes with 2,3-diphosphoglycerate for occu-
pancy of the central cleft in the deoxyHb tetramer 
(Weber et al. 2004). The rate of glycolysis, the 
pentose phosphate pathway, and a number of ion 
transport pathways in erythrocytes have been 
shown to depend on the state of Hb oxygenation. 
On Hb deoxygenation, glycolysis accelerates, the 
pentose phosphate pathway declines, the activities 
of the Na
+-K
+-2Cl
– cotransporter and the Na
+/H
+ 
exchanger (NHE) rise (Fig. 2).
The glycolytic machinery in the human eryth-
rocyte can compartimentalise ATP, allowing its 
direct consumption by ion pumps without release 
into the cytoplasm (Campanella et al. 2005). 
Phosphorylation of band 3 or deoxygenation of 
Hb can lead to release of GE from the membrane 
and accelerated glycolysis. Hb-cdb3 interaction 
could also mediate oxygen-sensitive ion trans-
port involved in erythrocyte volume and pHi 
regulation.
Erythrocytes, Oxygen Transport, 
and Oxygenation-dependent Signal 
Transduction Pathways
RBCs transport O2 to the tissues to support oxida-
tive phosphorylation. Bohr revealed the inﬂ  uence 
of pH/CO2 on O2 binding (Jensen, 2004). The 
reciprocal Haldane effect (inﬂ  uence of O2 binding 
on H
+/CO2 binding) has the same molecular origin. 
During oxygenation, tetrameric Hb undergoes a 
conformational change from the low affinity 
(tense, T) structure to the high-oxygenated 
(relaxed, R) structure that has a lower capacity for 
binding CO2, protons, chloride ions and organo-
phosphates. The allosteric interaction between O2 323
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and H
+ binding sites is further modulated by 
organic phosphates that bind preferentially to the 
T structure and decreases O2 afﬁ  nity.
Since Hb is located inside the RBC, the eryth-
rocyte pH is the true inﬂ  uential factor. In the steady 
state, both NHE and K
+-Cl
– cotransport are silent 
and the RBC resembles a Donnan system. When 
tissue O2 consumption increases, capillary PO2 
decreases and more O2 is extracted from the blood. 
The presence of CAII secures rapid CO2 hydration 
and RBC acidiﬁ  cation in tissue capillaries (Bohr 
shift). H
+ is bound to Hb, whereas HCO3
– is trans-
ported to plasma in exchange for Cl
–.
The role of the Hb oxy-deoxy conformational 
change in securing adequate O2 delivery may 
extend beyond the classical Bohr effect. In recent 
research, it has been suggested that RBCs play a 
role in local blood ﬂ  ow regulation by sensing O2 
demand and matching the release of vasodilatory 
compounds (Barvitenko et al. 2004; Robinson and 
Lancaster 2005; Han and Liao 2005). The nature 
of potential O2 sensors (Hb, heme-containing 
proteins, reactive O2 species, and changes in redox 
status) in erythrocytes remains unclear (Gibson 
et al. 2000).
Erythrocyte NHE
NHE is an oxygen-sensitive, electroneutral, 
secondary active transport, that catalyses amiloride 
sensitive exchange of one Na
+ for one H
+ under 
the inﬂ  uence of hormones and growth factors 
(Grinstein and Rothstein, 1986; Bourikas et al. 
2003). Intracellular pH is an important modulator 
of cell function since many enzymes exhibit pH 
dependence in the physiological range. Until now, 
pHi was assumed to be spatially uniform. How-
Band 3 dimer
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Figure 1. Schematic model of the organization of the cytoskeleton of human erythrocytes. The spectrin molecules form a mesh-like pattern 
(hexagonal) that is anchored to the membrane by ankyrin molecules.324
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ever, recent studies suggest the possibility of 
spatial nonuniformity of pHi. There could be pHi 
microdomains, just beneath the plasma membrane, 
where pHi is tightly regulated and modest 
ﬂ  uctuations in pHi arising during physiological 
cellular activity may inﬂ  uence the function of 
adjacent proteins (Willoughby et al. 2005; Ro and 
Carson, 2004). Nonuniform membrane distribu-
tion of NHE has been observed: it has been 
localized to lipid rafts or caveolae along with 
Ca
++-sensitive adenylyl cyclases. According to the 
model of “transport metabolons” (such as 
co-localised CAII-NHE and CAII-Na
+-HCO3 
cotransporter), H
+ ions generated by CAII activity 
may be channelled directly to the NHE for export, 
thus creating an alkaline pH microdomain. The 
dimensions and pH differentials of alkaline and 
acidic microdomains will depend on the relative 
production rates of HCO3
– and H
+ ions by CAII, 
the export rates of H
+, and HCO3
– by NHE and 
anion exchanger, respectively, and the diffusion 
rates of HCO3
– and H
+ ions in the cytoplasm. An 
acidic cluster of amino acid in the cytoplasmic 
C-terminal region of NHE mediates interaction 
with the basic N-terminal region of CAII, creating 
a transport complex or metabolon to facilitate H
+ 
export (Li et al. 2006).
NHE1 is a redox-regulated gene (Akram et al. 
2006). Reactive oxygen species regulate NHE1 
gene expression: O2
– anion induces NHE1 gene 
promoter activity resulting in increased NHE-1 
protein expression, which correlates with the 
Figure 2. Summary of membrane-bound transport systems involved in ion ﬂ  uxes between erythrocyte and blood. NHE: Na
+/H
+ exchanger. 
AE: Cl
−/HCO3
− anion exchanger.
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resistance of cells to death stimuli. In contrast, 
hydrogen peroxide suppresses NHE1 promoter 
activity and increases cell sensitivity to death 
triggers. These ﬁ  ndings have important clinical 
implications on account of the observed erythro-
cyte NHE hyperactivity in relation to chronic states 
of oxidative stress in humans (Matteucci and 
Giampietro, 2000a; Matteucci and Giampietro, 
2001; Matteucci and Giampietro, 2006; Matteucci 
and Giampietro, 2007a and b). Indeed, RBC NHE 
activity has been noted as being signiﬁ  cantly higher 
in type 1 diabetes (T1D) family members, 
independently of the presence of renal disease. 
Moreover, we found evidence of increased 
oxidative stress in the same nondiabetic normo-
tensive relatives of T1D patients, apart from 
soluble markers of autoimmunity and despite 
seemingly intact antioxidant defences. Markers of 
oxidation were associated with markers of inﬂ  am-
mation and we concluded that the familial increase 
in NHE activity could be ascribed to the direct 
stimulatory effect of oxidative stress.
Voltage-Dependent Anion-Selective 
Channel 1 (Vdac1) between
Mitochondria and Cytosol
VDAC1 (or porin) is a 30–35 kDa protein originally 
discovered in the outer membrane of mitochondria 
where it is the major pathway for metabolite (ADP/
ATP, succinate, citrate) exchange between the cyto-
sol and the mitochondria (Komarov et al. 2005). 
VDAC anchors both pro- and antiapoptotic proteins 
and could be part of the cytochrome c release chan-
nel in the outer membrane (intrinsic pathway of 
apoptosis). Predicted structural studies of human 
VDAC suggest the pore formed from a single layer 
of protein consisting of one α-helix and either 
13 or 16 membrane-spanning strands, curved into 
a cylinder (Baker et al. 2004). In the closed state, 
VDAC is slightly cation-selective; in the high con-
ductance conﬁ  guration (open state) it shows prefer-
ence for anions (Rostovtseva et al. 2005). Transition 
between the open and closed states is voltage-
dependent. At low voltages (30 mV) the posi-
tively charged voltage sensor forms part of the 
channel wall, at high voltages it moves out of the 
lumen causing channel closure (Lemasters and 
Holmuhamedov, 2006).
Although considered localized exclusively in 
the outer membrane and at contact sites of mito-
chondria, VDAC has also been found in the plasma 
membrane of most tissues, where it is concentrated 
in caveolae and caveolae-related domains (Bàthori 
et al. 1999). The presence of VDAC on erythrocyte 
plasma membrane has been conﬁ  rmed by using 
anti-VDAC antibodies (Shimizu et al. 2001). The 
function of porin in the plasma membrane remains 
unknown. Beyond known interactions with 
enzymes and apoptotic modulators, VDAC acts as 
an anchoring protein and may interact with several 
cytoskeletal elements (Roman et al. 2006).
Erythrocyte Plasma Membrane 
Oxidoreductases
Plasma membrane oxido-reductases (PMORs) are 
transmembrane electron transport systems that 
have been found in the membranes of all cells and 
have been extensively characterized in the human 
erythrocyte (Kennett and Kuchel, 2006). Erythro-
cyte PMORs transfer reducing equivalents from 
intracellular reductants to extracellular oxidants, 
thus their most important role seems to be to 
enable cell response to changes in intra- and extra-
cellular redox environments. Putative intracellular 
sources of reducing equivalents are NADH, 
NADPH, ascorbate, GSH, ﬂ  avonoids. Since tra-
ditionally PMOR activities were named after the 
oxidant used to identify them and the supposed 
intracellular electron donor, there is some confu-
sion on how many PMORs exist (Lawen et al. 
2005). The electron acceptor predominantly used 
to study PMORs is the membrane-impermeable 
ferricyanide that is reduced to ferrocyanide. The 
activity of these systems is strictly dependent on 
cell metabolic status and CO2 production through 
the oxidative pentose phosphate pathway. This 
activity was increased four-fold above controls in 
the presence of ferricyanide (May et al. 1996). The 
association of GE into multimeric complexes near 
cdb3 suggests a link between PMOR activity and 
metabolic control. As glycolytic ATP can be 
channelled to membrane ion pumps, reducing 
equivalents could be diverted from the glycolytic 
pathway across the membrane. Renegade electrons 
could be transported as NADH to the plasma 
membrane and extruded by the PMOR activities. 
Whenever PMOR function is perturbed, the pro-
duction of reactive species may increase. A 35 kDa 
NADH:ferricyanide reductase has been puriﬁ  ed 
from human plasma membrane preparations and 
identiﬁ  ed as VDAC1 (Baker et al. 2004). A dual 
role for the plasma membrane VDAC1 has been 326
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proposed, i.e. maintenance of cellular redox 
homeostasis in normal cells and cell volume 
regulation in apoptotic cells. The expression of 
functional VDAC activity has been induced by 
apoptotic stimuli in the plasma membrane of 
neuronal cell lines, and blocking this activity 
prevented apoptosis (Elinder et al. 2005).
Potential Role of Erythrocyte 
PMORs as Redox Biomarker
in Disease States
Despite increasing evidence in literature that 
PMORs in the plasma membrane may have several 
functions, little data exists about the erythrocyte 
electron transfer systems in humans. Ferricyanide 
reductase activity in a clinical setting was studied 
for the ﬁ  rst time in 1979 (Orringer and Roer, 1979). 
Chronic dialysis patients had higher pre-dialysis 
ferricyanide reductase activity than controls. 
However, the accelerated ferrocyanide generation 
was attributed to a “plasma factor”, probably iden-
tiﬁ  ed with ascorbic acid, since patients were given 
500 mg of ascorbic acid daily. Recently, the eryth-
rocyte velocity of ferricyanide reduction (RBC 
vfcy) has been reconsidered in uremic patients (not 
receiving daily vitamin C supplements) as well as 
the changes induced by a single hemodialysis 
session (Matteucci and Giampietro, 2007b). Pre-
dialysis RBC vfcy was maintained in the normal 
range on account of a reduced content of GSH and 
in spite of low plasma ascorbate. A single hemo-
dialysis treatment reduced biomarkers of protein 
and lipid oxidation but markedly impaired trans-
membrane electron transfer, which could be 
explained by acute depletion of electron donors. 
Indeed, immediately after the dialysis session RBC 
vfcy acutely and transiently decreases by about 
30%, and it occurs concomitantly with a further 
marked reduction in plasma vitamin C concentration 
(by about 64%).
In patients with type 1 diabetes (T1D) and dia-
betic nephropathy RBC vfcy was peculiarly 
elevated (Matteucci and Giampietro, 2000b). The 
abnormality was not contributed to by familiar or 
hereditary components (electron ﬂ  ow was normal 
in their non-diabetic siblings) but was suggestively 
attributed to chemical changes in the intervening 
medium. Theoretically, the magnitude of the 
current (Ii) across membrane ion channels depends 
on the density of channels (N), the conductance of 
the open channel (γ(V)), and its open probability 
(Po(V)) (Bezanilla, 2000). The conductance of one 
open channel γ(V) is constant unless there are 
extremely asymmetrical ionic conditions or a 
voltage-dependent block. Thus, the nonlinear 
dependence of Ii with voltage is the result of the 
modulation of the open probability Po of the 
channel by voltage. Functionally, there must be a 
device that detects the voltage across the membrane 
(Song et al. 1998). The voltage sensor could be a 
charged domain that moves along the electric ﬁ  eld, 
or a dipole that reorientate with respect to the 
electric field. For VDAC’s gating processes, 
decreasing the positive charge on the molecule, 
decreases the voltage-dependence and vice versa.
Noted in this respect, is the following:
•  massive protein oxidation occurs in vivo, par-
ticularly in diabetes mellitus and in nephrotic 
syndrome (Suzuki et al. 1992; Musante et al. 
2006),
•  the oxidation of the sulphydryl group of cyste-
ine to cysteic acid makes the surface charge 
more acidic in the pH range of ionization of this 
chemical group,
•  sulphenic transformation of thiol groups pre-
dicts formation of new hydrogen bonds with 
adjacent aminoacids.
For the above reasons, conformational rear-
rangements associated with oxidation of plasma 
membrane in diabetic nephropathy could be 
associated with deviations from normal channel 
activity. Additional in vivo factors can greatly 
inﬂ  uence the voltage-gating of VDAC channels 
and the resulting open probability will be the 
weighted sum of their effects (Colombini, 2004).
RBC vfcy has been further characterized in 
healthy subjects and T1D families with regard to: 
(a) the rate of electron transport in relation with 
body mass and metabolic efﬁ  ciency, and (b) the 
modulating effects of diet and lifestyle on eryth-
rocyte electron transfer system (Matteucci and 
Giampietro, 2006; Matteucci and Giampietro, 
2007a). Among healthy controls, individuals 
with BMI 25 kg/m
2 had lower RBC vfcy in 
comparison with subjects who were overweight 
or obese. RBC vfcy correlated positively with two 
indices of fat body mass (BMI and circulating 
triglycerides), and negatively with an index of lean 
body mass (24-hour urinary creatinine excretion). 
In healthy subjects, RBC vfcy showed a negative 
association with RBC NHE and plasma malondi-
aldheyde (MDA). To the contrary, among relatives, 327
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RBC vfcy did not change with BMI; moreover, it 
showed a positive association with RBC MDA, 
negative with RBC GSH. Stepwise multiple 
regression analyses including lifestyle information 
found different independent variables to be posi-
tively associated with RBC vfcy: daily dietary 
intake of vitamin C among healthy controls, 
whereas time spent in regular exercise among 
relatives. Thus, dietary intake of vitamin C and 
sporting activities modulated erythrocyte electron 
transfer efﬁ  ciency. It is noteworthy that, in the 
cytosol, ascorbic acid can donate electrons to RBC 
trans-plasma membrane electron transfer activity. 
In vitro, ascorbate may become the major electron 
donor, when cytosol ascorbate concentrations are 
increased by loading the cells with ascorbate, as 
well as a selective depletion of erythrocyte ascor-
bate therefore decreasing the capacity for ferri-
cyanide reduction. Moreover, indirect evidence 
suggested that regular exercise might improve 
electron transport efficiency (Matteucci and 
Giampietro, 2006).
The observation that RBC vfcy correlates 
negatively with RBC NHE activity deserves com-
ment. The unknown erythrocyte membrane com-
plex involved in the process of electron transfer 
could be inﬂ  uenced by changes in protonation 
status of the enzyme. Alternatively, the reduction 
of ferricyanide could be a non-electrogenic pro-
cess, unlike the reduction of ascorbate free radical 
(VanDuijn et al. 2001). In this case, NHE activity 
may prevent the electron shuttle in the plasma 
membrane to bind a proton when accepting an 
electron. A more plausible explanation, however, 
could be now suggested on the basis of evidence 
that oxidative stress activates NHE (Svegliati-
Baroni et al. 1999; Akram et al. 2006). In the 
healthy control group, RBC vfcy was negatively 
associated with at least two markers of oxidative 
damage, plasma MDA and RBC NHE activity, 
inasmuch as NHE has been suggested to represent 
a common mediator of the different effects induced 
by oxidative stress on cells. Furthermore, positive 
cooperativity has been found in the pH dependence 
of ion transport through the monomeric VDAC 
(Rostovtseva et al. 2000).
On the basis of present evidence we propose 
this scenario:
•  In diabetic nephropathy, RBC vfcy is overactive 
probably due to oxidation-induced changes in 
protein structure and charge.
•  In healthy subjects, erythrocytes supply elec-
trons to reduce extracellular oxidants, thus 
neutralising their noxious potential. Moreover, 
according to the model proposed by Morré et al. 
(2000), the PMOR maintains NAD
+/NADH 
homeostasis in mitochondrially deﬁ  cient cells 
through the regeneration of oxidised pyridine 
nucleotide to sustain glycolytic ATP production 
(Fig. 3).
•  In the relatives of T1D patients, vfcy is either 
positively associated with erythrocyte MDA, 
i.e. the product of the damaging effect exerted 
by radicals upon the cell membrane, and nega-
tively associated with the intracellular electron 
donor GSH. It is plausible that, under conditions 
of chronically increased radical generation as 
observed in T1D families, erythrocyte electron 
transfer may transform from a beneﬁ  cial elec-
tron carrier to a superoxide generator (Fig. 3). 
As a consequence, the transfer of electrons 
could result in the generation of ROS at the cell 
surface (Nohl et al. 1996) capable of propagat-
ing the oxidative cascade.
The erythrocyte electron transfer may reﬂ  ect 
the functional state of membrane proton pumps 
that modulate cellular metabolism by regulating 
the intracellular redox levels. Uncoupling, per-
haps as a feed back response to the overproduc-
tion of radicals by the electron transport chain, 
could represent a mechanism for the auto-
regulation of radical production, beyond its role 
in regulating thermogenesis. Recent observation 
that superoxide increases mitochondrial proton 
conductance and induces uncoupling (Echtay 
et al. 2002) supports the hypothesis. The dissipa-
tion of the protonmotive force by uncouplers 
might explain why relatives of type 1 diabetic 
patients show no relation between vfcy and fat 
body mass indices.
To conclude; the non uniform distribution of 
anion exchanger, glycolytic enzymes, NHE, 
VDAC and CA suggest the existence of wide 
structural and functional interrelationships among 
plasma membrane transporters and cytosolic 
enzymes with unexpected outcomes on cell 
physiology. The adaptations induced in PMOR 
function by disorders that affect cell redox state 
suggest these transmembrane electron transport 
systems as a potential marker of redox homeosta-
sis. Forthcoming biochemical investigations prom-
ise previously unimaginable implications for 328
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medical research focused to the comprehension of 
disease pathophysiology.
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